Drugs / NUMETA G13%E
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT03693287 | Jul 2021 → Aug 2023 | pulmonary immaturity | Ospedali Riuniti Ancona | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NUMETA G13%E | “NUMETA G13%E 300 mL is a triple-chamber (lipid emulsion, amino acids solution with electrolytes, and glucose solution), ready-to-use parenteral nutrition product available to...” NCT03693287 ↗ |
| Modality | Other / unclassified | “ready-to-use parenteral nutrition product” NCT03693287 ↗ |
| Route | Intravenous | “Intravenous macronutrient intakes” NCT03693287 ↗ |